Biochemical Implications of Ecstasy Toxicity

Henry JA Jeffreys K. J. Dawling S . Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). Lancet 1992; 340: 384–7.

O'Connor B . Hazards associated with the recreational drug ‘ecstasy’. Br J Hosp Med 1994; 52: 507–14.

Climko RP Roehrich H Sweeney DR Al-Razi J . Ecstasy: A review of MDMA and MDA. Int J Psychiatry Med 1987; 16: 359–72.

Tucker GT Lennard MS Ellis SW Woods HF Cho AK Lin LY . The demethylenation of methylenedioxymethamphetamine (“ecstasy”) by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol 1994; 47: 1151–6.

Harries DP De Silva RN . ‘Ecstasy’ and intracerebral haemorrhage. Scott Med J 1992; 37: 150–2.

Rothwell PM Grant R . Cerebral venous sinus thrombosis induced by ‘ecstasy’. J Neurol Neurosurg Psychiatry 1993; 56: 1035.

Watson JD Ferguson C Hinds CJ Skinner R Coakley JH . Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place? Anaesthesia 1993; 48: 1057–60.

Singarajah C Lavies NG . An overdose of ecstasy. A role for dantrolene. Anaesthesia 1992; 47: 686–7.

Maxwell DL Polkey MI Henry JA . Hyponatraemia and catatonic stupor after taking “ecstasy”. BMJ 1993; 307: 1399.

Satchell SC Connaughton M . Inappropriate antidiuretic hormone secretion and extreme rises in serum creatine kinase following MDMA ingestion. Br J Hosp Med 1994; 51: 495.